Market Cap

Peak Pharmaceuticals, Inc. Market Capitalization:

$607,316

USD as of July 1, 2023

business Peak Pharmaceuticals, Inc. Company Profile

Peak Pharmaceuticals, Inc. Main Stock Listing

OTC: PKPH

Market Capitalization History of Peak Pharmaceuticals, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Peak Pharmaceuticals, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2023 $11.4 M 45.00%
Jan. 1, 2022 $7.8 M 12.36%
Jan. 1, 2021 $7.0 M 709.09%
Jan. 1, 2020 $861,999 -89.91%
Jan. 1, 2019 $8.5 M -24.83%
Jan. 1, 2018 $11.4 M 61.11%
Jan. 1, 2017 $7.1 M 260.00%
Jan. 1, 2016 $2.0 M -86.11%
Jan. 1, 2015 $14.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Peak Pharmaceuticals, Inc. Categories

United States languages Healthcare languages Drug Manufacturers—Specialty & Generic
United States Healthcare United States Drug Manufacturers—Specialty & Generic

Stocks & Indices

Peak Pharmaceuticals, Inc. has the following listings and related stock indices.


Stock: OTC: PKPH

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.